AEGROS BIDCO LIMITED to acquire ALLIANCE PHARMA PLC

AEGROS BIDCO LIMITED has agreed to acquire Alliance Pharma PLC in a strategic acquisition within the pharmaceutical sector. The transaction was announced on 12 May 2025 and completed two days later on 14 May 2025. Consideration for the deal was provided entirely in cash, although the specific financial value of the transaction was not disclosed to the public. The target company operates from the United Kingdom, and the deal represents a significant consolidation within the industry.

The acquisition marks the conclusion of the negotiation phase, with the transaction now fully completed. Regulatory approvals were secured to facilitate the transfer of ownership from the public company to the new private owner. This strategic move allows the buyer to integrate the target's assets and operations into its existing portfolio. The deal structure ensures a clean transition of control without the need for further regulatory intervention. The transaction is now final and effective.